Life Science Compliance Update

January

2018

The Monster in the Closet – New WHO Report Shines a Light on the Problem of Substandard & Falsified Medicines

Written by , Posted in Uncategorized

Gwendolyn Ball, Staff Writer, Life Science Compliance Update

The issue of substandard and counterfeit medicines has been known for some time. Since it is not often discussed openly, it is difficult to get an appreciation for the scope of the problem. However, a new WHO report, backed by four years’ worth of data, sheds some light on the matter and gives some guidance on how to identify likely problems and respond to them.


   or   


November

2017

Why it matters – Pharmaceutical compliance, Anti-corruption and Access to Medicine

Written by , Posted in Uncategorized

Luca Genovese and Danny Edwards, The Access to Medicine Foundation

Access to medicine continues to be out of reach for an estimated two billion people worldwide. While it is clear that corruption plays a role in that problem, the true scope and cost of global health corruption is unknown. This article examines what pharmaceutical companies do and what role they should play in eliminating corruption as part of the equation of ensuring access.


   or   


Menu Title